Blue Book section 13.00, Cancer
Cancer and Social Security Disability: The 13.00 Listings
Each cancer is matched to the Blue Book listing for its site of origin, then measured by extent, response to anticancer therapy, and lasting effects of the cancer or its treatment. Section 13.00 holds one listing per origin site, from 13.02 head and neck through 13.29 malignant melanoma.
Two people with the same diagnosis can stand in very different places in a cancer claim. Section 13.00 of the Blue Book ties each listing to the body site where the cancer started, and most listings turn on facts an oncologist records: whether the cancer is inoperable or unresectable, whether it has spread beyond the regional lymph nodes, whether it returned after treatment.
For an SSDI (Social Security Disability Insurance) or SSI (Supplemental Security Income) claim, the pathology report and the treatment timeline carry as much weight as the diagnosis. The sections below cover how the listings are organized, the timing rules, the RFC route, the evidence SSA asks for, and why these claims stall.
SSA Blue Book listing
13.00 (listings 13.02 to 13.29)
Cancer, metabolic and other
The criteria are set out below in plain language.
SSA Blue Book, 13.00 Cancer (Malignant Neoplastic Diseases) (Adult)
How the 13.00 cancer listings are organized by site
Section 13.00 runs from 13.02 through 13.29, and each listing applies only to cancer that originated at that site. Breast cancer that spreads to bone is still evaluated under 13.10, Breast. For every listing, SSA considers the origin of the cancer, the extent of involvement, the duration, frequency and response to anticancer therapy, and the effects of any residual impairment after treatment.
Two listings show how the criteria read in practice:
- 13.10 Breast is met by locally advanced cancer (inflammatory carcinoma, cancer of any size extending to the chest wall or skin, or cancer with metastases to the internal mammary nodes on the same side); carcinoma with metastases to the supraclavicular or infraclavicular nodes, to 10 or more axillary nodes, or to distant sites; recurrent carcinoma, except local recurrence that responds to anticancer therapy; small-cell carcinoma; or secondary lymphedema caused by therapy and treated by surgery to salvage or restore arm function, considered disabling for at least 12 months from that surgery.
- 13.14 Lungs is met by non-small-cell carcinoma that is inoperable, unresectable, recurrent, or metastatic to or beyond the hilar nodes; by small-cell carcinoma; or by superior sulcus carcinoma, including Pancoast tumors, treated with multimodal anticancer therapy, considered disabling for at least 18 months from diagnosis.
Some listings sit outside the site-by-site pattern. Listing 13.27 covers cancer whose primary site cannot be found, using evidence of the metastatic sites. Listing 13.28 covers cancer treated by bone marrow or stem cell transplantation, which must already have occurred.
How long does SSA consider cancer disabling after treatment?
The timing rules in 13.00 decide when a claim can be evaluated and how long a listing-level finding lasts.
- Response to treatment. Cancer that has spread beyond the regional lymph nodes usually meets a listing without a longitudinal record, unless it is expected to respond to therapy; then SSA usually needs about 3 months of records after therapy starts. For other cancers, SSA looks at the response to the initial planned treatment, and with a single type of therapy, enough time must pass to see whether it worked.
- Multimodal therapy. When treatments such as surgery, radiation and chemotherapy are given together as one planned regimen, SSA usually waits until the effects of all planned modalities can be determined, unless a fully favorable decision can be made sooner. For listings 13.02E, 13.11D and 13.14C, multimodal therapy counts as started on the date the first modality begins.
- Persistent, recurrent or progressive disease. Many listings are met only when therapy fails and the cancer persists, progresses or recurs. Section 13.00 defines progressive as cancer that grows after at least half of the planned initial therapy.
- The 3-year rule. Unless a listing says otherwise, an impairment that meets a 13.00 listing is considered disabling until at least 3 years after the onset of complete remission. After 3 years with no evidence of tumor or metastases, it no longer meets the listing and SSA evaluates the residual effects. A recurrence may meet a listing again.
- Transplants. Under section 13.00L, acute leukemia is considered disabling for at least 24 months from diagnosis or relapse, or 12 months from transplant, whichever is later. Lymphoma, multiple myeloma and chronic-phase CML are considered disabling for at least 12 months from transplant. Listing 13.28 covers other cancers treated with a bone marrow or stem cell transplant.
Section 13.00J also allows SSA to set an onset date earlier than the date the cancer first met a listing, based on the type and location of the cancer, its extent when first shown, and your symptoms. An earlier onset can change the back pay period.
The RFC route when cancer does not meet a listing
Duration rule
12months
Section 13.00 states that its listings are examples. If none is met, SSA must consider listings in other body systems, medical equivalence, and the fourth and fifth steps of the sequential evaluation, where your RFC (residual functional capacity), the most you can still do on a sustained basis, is the measure. Section 13.00G adds that treatment side effects are usually temporary but can be disabling for at least 12 months, and that when therapy works, the remaining effects are evaluated under the affected body system.
The cancer RFC usually comes from the treatment as much as the tumor:
- Chemotherapy fatigue and neuropathy limit stamina, standing and fine hand use, and infusion cycles produce scheduled absences.
- Radiation to the chest can reduce exercise tolerance, and radiation to the head and neck can affect swallowing and speech.
- Surgery leaves its own limits, such as reduced arm use after axillary node dissection or lifting restrictions after abdominal surgery.
- Lymphedema restricts repetitive reaching, lifting and handling with the affected arm.
- Cognitive effects reported during and after treatment can limit concentration and pace.
- Anxiety and depression after diagnosis belong in the file as separate impairments when they are treated.
Because 13.00G tells adjudicators to review the specific drugs, dosages, extent of surgery, radiation details and complications, the treatment record itself is the RFC evidence.
Medical evidence that decides a cancer disability claim
Section 13.00D asks for records that state the type, extent and site of the cancer. When there was a biopsy or surgery, SSA generally needs the operative note and the pathology report. If those cannot be obtained, a hospital summary or other medical report describing the surgical and pathological findings can stand in.
The records we gather in cancer files:
- Pathology reports with tumor type, grade, margins and lymph node counts, which bear directly on criteria such as the 10-node threshold in 13.10.
- Operative notes stating whether a tumor was resected and whether resection was complete, the facts behind inoperable and unresectable findings.
- Staging imaging such as CT, PET or MRI, and later scans showing response, persistence, progression or recurrence.
- Oncology treatment plans naming every planned modality, so the multimodal timing in 13.00E can be applied.
- Infusion and radiation records with dates, plus notes on side effects and dose reductions.
- For leukemia, bone marrow results: 13.00 states that acute leukemia is diagnosed by bone marrow examination, and chronic lymphocytic leukemia is documented by lymphocytosis of at least 10,000/mm³ for 3 months or longer, or by other acceptable diagnostic techniques.
Why cancer disability claims are denied or delayed
The pattern we see in denied cancer claims is a file assessed on the diagnosis date instead of the treatment course. A claim filed in the first weeks after surgery may arrive before the pathology report, before the oncologist sets the treatment plan, and before anyone knows whether the cancer responded. Under 13.00E, a claim involving multimodal therapy usually cannot be fully evaluated until the effects of all planned modalities are known. If the cancer was resected with clear margins, the listing language about inoperable, recurrent or metastatic disease will not match, and the claim has to be rebuilt around the RFC.
The second pattern is a claim whose evidence ends at remission. Side effects that outlast treatment, such as neuropathy, lymphedema or heart effects of some therapies, are evaluated under the affected body system, and they need their own records from the specialists treating them. If a denial has arrived on a claim like this, what to do after a denial starts with filling those gaps.
Cancer Disability Claim Questions
Can a cancer disability claim be fast-tracked?
Some can. SSA keeps a fast-track list of conditions called Compassionate Allowances, and its selection software flags claims based on the impairments named on the disability report. Those cases are processed as expedited. The list includes pancreatic cancer, esophageal cancer, small cell lung cancer and acute leukemia, among others. The field office still develops the non-medical requirements, so name your exact diagnosis on the application.
Is a brain tumor evaluated under the cancer listings?
It depends on the tumor. Section 13.00 evaluates primary central nervous system cancers under listing 13.13 and treats grade II through IV tumors as malignant. Benign brain tumors are evaluated under listing 11.05 in the neurological section instead. The pathology grade in the surgical or biopsy report decides which section applies.
Does carcinoma in situ count as cancer for a disability claim?
Not under the 13.00 listings. Section 13.00 excludes carcinoma-in-situ from the term carcinoma, so in situ disease cannot meet a cancer listing on that basis. A claim can still rest on the effects of treatment, such as surgery or radiation complications, if they limit work for at least 12 months and the records show it.
Sources: SSA Blue Book, 13.00 Cancer (Malignant Neoplastic Diseases) (Adult); SSA Compassionate Allowances conditions list; SSA POMS DI 23022.010, Compassionate Allowances and QDD fast-track processes.
Free case review
A condition that keeps you from working deserves a complete file
Tell us where your claim stands and what your records show. We respond within 3 business hours, and there is no fee unless you win.